Related Experiment Videos
EEG diagnostic and predictive value on HIV infection in childhood
P Vigliano1, R Rigardetto, G Capizzi
1University of Turin, Cattedra di Neuropsichiatria Infantile, Italy.
Insights
Electroencephalography (EEG) helps detect early central nervous system (CNS) damage in children with HIV. This diagnostic tool aids in identifying and tracking the development of encephalopathy in affected pediatric patients.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Neurophysiology
Background:
- Childhood HIV infection poses risks for central nervous system (CNS) development.
- Early detection of CNS abnormalities is crucial for managing pediatric HIV.
- Electroencephalography (EEG) is a non-invasive tool for assessing brain function.
Purpose of the Study:
- To evaluate the diagnostic and prognostic utility of EEG in children with HIV infection.
- To assess the correlation between EEG findings and the development of encephalopathy.
- To determine the role of EEG in monitoring CNS damage over time.
Main Methods:
- Prospective study of 125 HIV-seropositive children.
- Serial EEG recordings every three months in infancy, then annually.
- Blind comparison of EEG data from HIV-infected children (P2 group) with a seroconverted control group.
Main Results:
- Normal EEG results were observed in non-encephalopathic HIV-infected children (P0, P1) and controls.
- Abnormal EEG findings were present in 35.5% of the P2 group (HIV-infected with potential CNS involvement).
- Of those with abnormal EEGs, 54.6% developed encephalopathy, with onset ranging from 2.5 months to 2 years 11 months post-diagnosis.
Conclusions:
- EEG is a valuable tool for early diagnosis of CNS damage in pediatric HIV.
- EEG aids in identifying the onset and monitoring the evolution of encephalopathy in HIV-infected children.
- Serial EEG assessments can inform prognostic evaluations and management strategies for CNS complications in childhood HIV.
Abstract:
This prospective study evaluated the electroencephalographic (EEG) diagnostic and prognostic value in childhood HIV infection. It was carried out on 125 subjects and included all Piemonte's seropositive children. The EEG was repeated every three months during the first 15 months of life, and then, at least, annually in the P1 and P2 group. Data of group P2 was compared blindly to that of the seroconverted control group of the same age and risk. EEG results were normal in P0, P1 and control patients. In group P2, EEG was abnormal in 35.5% of subjects, of these 54.6% developed an encephalopathy with a delay of 2.5 months to 2 years 11 months. EEG is therefore useful to evaluate early CNS damage and to identify onset features and evolution of encephalopathy in P2 patients.